NEW YORK, Oct. 7, 2016 /PRNewswire/ -- Levi & Korsinsky, LLP announces that it has commenced an investigation of ProNAi Therapeutics Inc. ("ProNAi" or the "Company") (NASDAQ: DNAI) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. To obtain additional information about the investigation, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investor-alert-levi--korsinsky-llp-announces-an-investigation-involving-possible-securities-fraud-violations-by-pronai-therapeutics-inc-and-certain-officers-and-directors----dnai-300341449.html
SOURCE Levi & Korsinsky, LLP